Coronary artery spasm: Review and update

International Journal of Medical Sciences

Volumn 11, Issue 11, 2014, Pages 1161-1171

  Hung, Ming Jui ^a   Hu, Patrick ^b,c   Hung, Ming Yow ^a,d,e  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b International Cardiovascular Institute   (United States)

^c Riverside Medical Clinic   (United States)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Coronary artery spasm; Prinzmetal's angina; Provocative testing

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ANGINA PECTORIS, VARIANT; CORONARY ARTERY DISEASE; CORONARY VASOSPASM; HUMAN; PATHOLOGY;

ANGINA PECTORIS, VARIANT; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERY DISEASE; CORONARY VASOSPASM; HUMANS;

EID: 84906822000     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.9623     Document Type: Review

References (153)

1. Maseri A, Parodi O, Severi S, Pesola A. Transient transmural reduction of myocardial blood flow demonstrated by thallium-201 scintigraphy, as a cause of variant angina. Circulation. 1976; 54: 280-288.
2. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959; 27: 375-388.
3. Heberden W. Some account of a disorder of the breast. Medical Transactions. 1772; 2: 59-67.
4. MacAlpin RN, Kattus AA, Alvaro AB. Angina pectoris at rest with preservation of exercise capacity: Prinzmetal's variant angina. Circulation. 1973; 47: 946-958.
5. Sones FM Jr, Shirey EK. Cine coronary arteriography. Mod Concepts Cardiovasc Dis. 1962; 31: 735-738.
6. Oliva PB, Potts DE, Pluss RG. Coronary arterial spasm in prinzmetal angina. Documentation by coronary arteriography. N Engl J Med. 1973; 288: 745-751.
7. Cheng TO, Bashour T, Kelser GA, Jr., Weiss L, Bacos J. Variant angina of prinzmetal with normal coronary arteriograms. A variant of the variant. Circulation. 1973; 47: 476-485.
8. Maseri A, Mimmo R, Chierchia S, Marchesi C, Pesola A, L'Abbate A. Coronary artery spasm as a cause of acute myocardial ischemia in man. Chest. 1975; 68: 625-633.
9. JCS Joint Working Group. Japanese Circulation Society of Guidelines for Diagnosis and Treatment of Patients with Vasospastic Angina (Coronary Spastic Angina) (JCS 2008): digest version. Cir J. 2010; 74: 1745-1762.
10. Cheng CW, Yang NI, Lin KJ, Hung MJ, Cherng WJ. Role of coronary spasm for a positive noninvasive stress test result in angina pectoris patients without hemodynamically significant coronary artery disease. Am J Med Sci. 2008; 335: 354-362.
11. Nakagawa H, Morikawa Y, Mizuno Y, et al. Coronary spasm preferentially occurs at branch points: an angiographic comparison with atherosclerotic plaque. Circ Cardiovasc Interv. 2009; 2: 97-104.
12. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol. 1999; 33: 1442-1452.
13. Sueda S, Kohno H, Fukuda H, et al. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology. 2004; 55: 403-411.
14. Hung MY, Hsu KH, Hung MJ, Cheng CW, Cherng WJ. Interactions among gender, age, hypertension and C-reactive protein in coronary vasospasm. Eur J Clin Invest. 2010; 40: 1094-1103.
15. Bertrand ME, LaBlanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation. 1982; 65: 1299-1306.
16. Hung MJ, Cherng WJ, Cheng CW, Li LF. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. Am J Cardiol. 2006; 97: 1429-1434.
17. Hung MJ, Cheng CW, Yang NI, Hung MY, Cherng WJ. Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease. Int J Cardiol. 2007; 117: 37-44.
18. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol. 2008; 52: 523-527.
19. Maseri A, L'Abbate A, Baroldi G, et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med. 1978; 299: 1271-1277.
20. Yasue H, Kugiyama K. Coronary spasm: clinical features and pathogenesis. Intern Med. 1997; 36: 760-765.
21. Hung MJ, Hung MY, Cheng CW, Yang NI, Cherng WJ. Clinical characteristics of patients with exercise-induced ST-segment elevation without prior myocardial infarction. Circ J. 2006; 70: 254-261.
22. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation. 1987; 75: 1110-1116.
23. Maseri A, Severi S, Nes MD, et al. "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol. 1978; 42: 1019-1035.
24. Hillis LD, Braunwald E. Coronary-artery spasm. N Engl J Med. 1978; 299: 695-702.
25. Araki H, Koiwaya Y, Nakagaki O, Nakamura M. Diurnal distribution of ST-segment elevation and related arrhythmias in patients with variant angina: a study by ambulatory ECG monitoring. Circulation. 1983; 67: 995-1000.
26. Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circ Res. 1983; 52: I147-152.
27. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. J Cardiol. 2008; 51: 2-17.
28. Jougasaki M, Yasue H, Takahashi K. Perivascular nerve lesion of the coronary artery involved in spasm in a patient with variant angina. Pathology. 1989; 21: 304-307.
29. Otsuka K, Yanaga T, Watanabe H. Variant angina and REM sleep. Am Heart J. 1988; 115: 1343-1346.
30. Yasue H, Omote S, Takizawa A, et al. Comparison of coronary arteriographic findings during angina pectoris associated with S-T elevation or depression. Am J Cardiol. 1981; 47: 539-546.
31. Ozaki Y, Keane D, Serruys PW. Fluctuation of spastic location in patients with vasospastic angina: a quantitative angiographic study. J Am Coll Cardiol. 1995; 26: 1606-1614.
32. Waters DD, Szlachcic J, Theroux P, Dauwe F, Mizgala HF. Ergonovine testing to detect spontaneous remissions of variant angina during long-term treatment with calcium antagonist drugs. Am J Cardiol. 1981; 47: 179-184.
33. Whittle JL, Feldman RL, Pepine CJ, Curry RC, Conti CR. Variability of electrocardiographic responses to repeated ergonovine provocation in variant angina patients with coronary artery spasm. Am Heart J. 1982; 103: 161-167.
34. Seniuk W, Mularek-Kubzdela T, Grygier M, Grajek S, Cieśliński A. Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study. J Intern Med. 2002; 252: 368-376.
35. Hung MJ, Wang CH, Kuo LT, Cherng WJ. Coronary artery spasm-induced paroxysmal atrial fibrillation--a case report. Angiology. 2001; 52: 559-562.
36. Myerburg RJ, Kessler KM, Mallon SM, et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. N Engl J Med. 1992; 326: 1451-1455.
37. Maseri A, Severi S, Marzullo P. Role of coronary arterial spasm in sudden coronary ischemic death. Ann N Y Acad Sci. 1982; 382: 204-217.
38. Romagnoli E, Lanza GA. Acute myocardial infarction with normal coronary arteries: role of coronary artery spasm and arrhythmic complications. Int J Cardiol. 2007; 117: 3-5.
39. th ed. Philadelphia: Saunders, 2005; 853.
40. Hung MY, Hung MJ, Cheng CW, Yang NI, Cherng WJ. Safety and predictors of a positive result of intracoronary ergonovine testing in patients with ischemic heart disease without hemodynamically significant coronary artery stenosis in Taiwan. Acta Cardiol Sin. 2007; 23: 150-159.
41. Choquette G, Wasserman F, Lisker S, Bellet S. Spontaneous reversion of ventricular fibrillation to normal sinus rhythm in a case of acute myocardial infarction. Am Heart J. 1956; 51: 455-459.
42. Patt MV, Podrid PJ, Friedman PL, Lown B. Spontaneous reversion of ventricular fibrillation. Am Heart J. 1988; 115: 919-923.
43. Dubner SJ, Gimeno GM, Elencwajg B, Leguizamón J, Trongé JE, Quinteiro R. Ventricular fibrillation with spontaneous reversion on ambulatory ECG in the absence of heart disease. Am Heart J. 1983; 105: 691-693.
44. Farmer DM, Swygman CA, Wang PJ, Mark Estes NA 3rd, Link MS. Evidence that nonsustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators). Am J Cardiol. 2003; 91: 606-609.
45. Hung MJ, Hsu KH, Hu WS, Chang NC, Hung MY. C-reactive protein for predicting prognosis and its gender-specific associations with diabetes mellitus and hypertension in the development of coronary artery spasm. PLoS One. 2013; 8: e77655.
46. Takaoka K, Yoshimura M, Ogawa H, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol. 2000; 72: 121-126.
47. Hung MY, Hsu KH, Hung MJ, et al. Interaction between cigarette smoking and high-sensitivity C-reactive protein in the development of coronary vasospasm in patients without hemodynamically significant coronary artery disease. Am J Med Sci. 2009; 338: 440-446.
48. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993; 87: 76-79.
49. Takagi Y, Takahashi J, Yasuda S, et al; Japanese Coronary Spasm Association. Prognostic stratification of patients with vasospastic angina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association. J Am Coll Cardiol. 2013; 62: 1144-1153.
50. Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation. 2000; 101: 1102-1108.
51. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H. Coronary spasm is associated with chronic low-grade inflammation. Circ J. 2007; 71: 1074-1078.
52. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res. 2002; 53: 538-549.
53. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937-952.
54. Yeung AC, Vekshtein VI, Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med. 1991; 325: 1551-1556.
55. Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest. 2000; 118: 1690-1695.
56. Fernandez D, Rosenthal JE, Cohen LS, Hammond G, Wolfson S. Alcohol-induced Prinzmetal variant angina. Am J Cardiol. 1973; 32: 238-239.
57. Oi K, Shimokawa H, Hiroki J, et al. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arterioscler Thromb Vasc Biol. 2004; 24: 918-922.
58. Pitts WR, Lange RA, Cigarroa JE, Hillis LD. Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management. Prog Cardiovasc Dis. 1997; 40: 65-76.
59. Hung MY, Hsu KH, Hu WS, Chang NC, Huang CY, Hung MJ. Gender-specific prognosis and risk impact of C-reactive protein, hemoglobin and platelet in the development of coronary spasm. Int J Med Sci. 2013; 10: 255-264.
60. Heupler FA Jr, Proudfit WL, Razavi M, Shirey EK, Greenstreet R, Sheldon WC. Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol. 1978; 41: 631-640.
61. Tada M, Kuzuya T, Inoue M, et al. Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris. Circulation. 1981; 64: 1107-1115.
62. Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?. Int J Cardiol. 2006; 110: 7-14.
63. Yasue H, Horio Y, Nakamura N, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation. 1986; 74: 955-963.
64. Kugiyama K, Yasue H, Horio Y, Morikami Y, Fujii H, Kimura T. Possible role of parasympathetic nervous system in the pathogenesis of exercise-induced coronary artery spasm. Am Heart J. 1986; 112: 605-606.
65. Waters DD, Miller DD, Bouchard A, Bosch X, Theroux P. Circadian variation in variant angina. Am J Cardiol. 1984; 54: 61-64.
66. Kaski JC, Maseri A, Vejar M, Crea F, Hackett D. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol. 1989; 14: 1456-1463.
67. Lanza GA, Pedrotti P, Pasceri V, Lucente M, Crea F, Maseri A. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol. 1996; 28: 1249-1256.
68. Robertson RM, Bernard Y, Robertson D. Arterial and coronary sinus catecholamines in the course of spontaneous coronary artery spasm. Am Heart J. 1983; 105: 901-906.
69. King MJ, Zir LM, Kaltman AJ, Fox AC. Variant angina associated with angiographically demonstrated coronary artery spasm and REM sleep. Am J Med Sci. 1973; 265: 419-422.
70. El Menyar AA. Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. J Postgrad Med. 2006; 52: 51-56.
71. Raizner AE, Chahine RA, Ishimori T, et al. Provocation of coronary artery spasm by the cold pressor test. Hemodynamic, arteriographic and quantitative angiographic observations. Circulation. 1980; 62: 925-932.
72. Shirotani M, Yokota R, Kouchi I, et al. Influence of atenolol on coronary artery spasm after acute myocardial infarction in a Japanese population. Int J Cardiol. 2010; 139: 181-186.
73. Svendsen TL. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity. J Cardiovasc Pharmacol. 1983; 5 (Suppl 1): S21-25.
74. Tilmant PY, Lablanche JM, Thieuleux FA, Dupuis BA, Bertrand ME. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol. 1983; 52: 230-233.
75. Kazanietz MG, Enero MA. Desensitization of the beta-2 adrenoceptor-mediated vasodilation in rat aorta after prolonged treatment with the beta-2 adrenoceptor agonist clenbuterol. J Pharmacol Exp Ther. 1990; 252: 758-764.
76. Yasue H, Hirai N, Mizuno Y, et al. Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J. 2006; 70: 8-13.
77. Lewis JR, Kisilevsky R, Armstrong PW. Prinzmetal's angina, normal coronary arteries and pericarditis. Can Med Assoc J. 1978; 119: 36-39.
78. Hung MJ, Cherng WJ, Hung MY, et al. Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina. Atherosclerosis. 2012; 221: 521-526.
79. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J. 2000; 64: 1-12.
80. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ 2nd, Virmani R. Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med. 1985; 313: 1138-1141.
81. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation. 1985; 71: 709-716.
82. Kugiyama K, Yasue H, Okumura K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation. 1996; 94: 266-271.
83. Nakayama M, Yasue H, Yoshimura M, et al. T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999; 99: 2864-2870.
84. Motoyama T, Kawano H, Kugiyama K, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol. 1998; 32: 1672-1679.
85. Yasue H, Mizuno Y, Harada E, et al; SCAST (Statin and Coronary Artery Spasm Trial) Investigators. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol. 2008; 51: 1742-1748.
86. Okumura K, Yasue H, Matsuyama K, et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol. 1996; 27: 45-52.
87. Egashira K, Inou T, Yamada A, Hirooka Y, Takeshita A. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest. 1992; 89: 1047-1052.
88. Ito K, Akita H, Kanazawa K, et al. Systemic endothelial function is preserved in men with both active and inactive variant angina pectoris. Am J Cardiol. 1999; 84: 1347-1349.
89. Kandabashi T, Shimokawa H, Miyata K, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation. 2000; 101: 1319-1323.
90. Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Ishii Y, Tanaka K, Nakamura M. Coronary artery spasm induced in miniature swine: angiographic evidence and relation to coronary atherosclerosis. Am Heart J. 1985; 110: 300-310.
91. Kandabashi T, Shimokawa H, Miyata K, et al. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm. Arterioscler Thromb Vasc Biol. 2003; 23: 2209-2214.
92. Shimokawa H, Seto M, Katsumata N, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 1999; 43: 1029-1039.
93. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 2002; 105: 1545-1547.
94. Chutkow WA, Pu J, Wheeler MT, et al. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin Invest. 2002; 110: 203-208.
95. Kakkar R, Ye B, Stoller DA, et al. Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ Res. 2006; 98: 682-689.
96. Chen CC, Lamping KG, Nuno DW, et al. Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. Science. 2003; 302: 1416-1418.
97. Ota Y, Kugiyama K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract--role of free radicals and attenuation by captopril. Atherosclerosis. 1997; 131: 195-202.
98. Sugiyama S, Kugiyama K, Ohgushi M, et al. Supersensitivity of atherosclerotic artery to constrictor effect of cigarette smoke extract. Cardiovasc Res. 1998; 38: 508-515.
99. Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol. 1996; 28: 1161-1167.
100. Motoyama T, Kawano H, Kugiyama K, et al. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol. 1997; 273(4 Pt 2): H1644-650.
101. Rodrigo R, González J, Paoletto F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res. 2011; 34: 431-440.
102. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H. Vitamin E deficiency in variant angina. Circulation. 1996; 94: 14-18.
103. Miyamoto S, Kawano H, Sakamoto T, et al. Increased plasma levels of thioredoxin in patients with coronary spastic angina. Antioxid Redox Signal. 2004; 6: 75-80.
104. Egashira K, Katsuda Y, Mohri M, et al. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol. 1996; 27: 1444-1449.
105. Miwa K, Fujita M, Sasayama S. Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm. Heart Vessels. 2005; 20: 1-7.
106. Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998; 103: 65-69.
107. Kaneda H, Taguchi J, Kuwada Y, et al. Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene. Circ J. 2006; 70: 409-413.
108. Ito T, Yasue H, Yoshimura M, et al. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet. 2002; 110: 89-94.
109. Park JS, Zhang SY, Jo SH, et al. Common adrenergic receptor polymorphisms as novel risk factors for vasospastic angina. Am Heart J. 2006; 151: 864-869.
110. Kaumann AJ, Levy FO. 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol Ther. 2006; 111: 674-706.
111. Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K. Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. J Clin Invest. 1995; 96: 2975-2979.
112. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation. 1998; 97: 135-137.
113. Nakano T, Osanai T, Tomita H, Sekimata M, Homma Y, Okumura K. Enhanced activity of variant phospholipase C-delta1 protein (R257H) detected in patients with coronary artery spasm. Circulation. 2002; 105: 2024-2029.
114. Murase Y, Yamada Y, Hirashiki A, et al. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J. 2004; 25: 970-977.
115. Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation. 2011; 124: 1774-1782.
116. Cheng TO. Ergonovine test for coronary artery spasm. Int J Cardiol. 2007; 114: 249-250.
117. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999; 33: 1756-1824.
118. Baim DS. Coronary angiography. In: Baim DS, eds. Grossman's cardiac catheterization, angiography, and intervention. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2006: 215.
119. Bertrand ME, Lablanche JM, Tilmant PY, Thieuleux FA, Delforge MG, Chahine RA. The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. Eur Heart J. 1983; 4: 532-535.
120. Hamilton KK, Pepine CJ. A renaissance of provocative testing for coronary spasm? J Am Coll Cardiol. 2000; 35: 1857-1859.
121. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 1985; 232: 708-716.
122. Shimokawa H, Flavahan NA, Shepherd JT, Vanhoutte PM. Endothelium-dependent inhibition of ergonovine-induced contraction is impaired in porcine coronary arteries with regenerated endothelium. Circulation. 1989; 80: 643-650.
123. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288: 373-376.
124. Zaya M, Mehta PK, Bairey Merz CN. Provocative Testing for Coronary Reactivity and Spasm. J Am Coll Cardiol. 2014; 63: 103-109.
125. Buxton A, Goldberg S, Hirshfeld JW, et al. Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol. 1980; 46: 329-334.
126. Harding MB, Leithe ME, Mark DB, et al. Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. J Am Coll Cardiol. 1992; 20: 107-111.
127. Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation. 1987; 75: 577-582.
128. Okumura K, Yasue H, Horio Y, et al. Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. Circulation. 1988; 77: 535-542.
129. Cheng TO. Coronary artery spasm--1984. Chest. 1984; 86: 918-926.
130. Previtali M, Ardissino D, Barberis P, Panciroli C, Chimienti M, Salerno JA. Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. Am J Cardiol. 1989; 63: 17-20.
131. Eshaghpour E, Mattioli L, Williams ML, Moghadam AN. Acetylcholine in the treatment of idiopathic respiratory distress syndrome. J Pediatr. 1967; 71: 243-246.
132. Fournier JA, Cortacero JA, Turá A, Hernández-Aparicio C, Granado C, Vallejo J. Effects of intracoronary injection of ergonovine on angiographic normal coronary arteries: study of 108 consecutive patients. Clin Cardiol. 1989; 12: 561-568.
133. de Lemons JA, O'Rourke RA. Unstable angina and non-ST-segment elevation myocardial infarction. In: Fuster V, Eds. Hurst's The Heart. 12th ed. New York: McGraw-Hill; 2008: 1371-1372.
134. [Internet] Pinto DS, Beltrame JF, Crea F. Variant angina. http://www.uptodate.com/contents/variant-angina?source=search_result&search =variant+angina&selectedTitle=1%7E103.
135. Kaski JC. Management of vasospastic angina--role of nicorandil. Cardiovasc Drugs Ther. 1995; 9 (Suppl 2): 221-227.
136. Bertrand ME, LaBlanche JM, Thieuleux FA, Fourrier JL, Traisnel G, Asseman P. Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. J Am Coll Cardiol 1986; 8: 504-508.
137. Bertrand ME, Lablanche JM, Rousseau MF, Warembourg HH Jr, Stankowtak C, Soots G. Surgical treatment of variant angina: use of plexectomy with aortocoronary bypass. Circulation 1980; 61: 877-882.
138. Gaspardone A, Tomai F, Versaci F, et al. Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol. 1999; 84: 96-98.
139. Chou HH, Lim KE, Ko YL. Treatment of spontaneous left main coronary artery spasm with a drug-eluting stent. Acta Cardiol Sin. 2009; 25: 43-46.
140. Chou MT, Huang TY. Coronary stenting for coronary vasospasm complicated with refractory ventricular tachycardia and fibrillation. Acta Cardiol Sin. 2012; 28: 145-147.
141. Nakamura T, Furukawa K, Uchiyama H, Seo Y, Okuda S, Ebizawa T. Stent placement for recurrent vasospastic angina resistant to medical treatment. Cathet Cardiovasc Diagn 1997; 42: 440-443.
142. th ed. Philadelphia: Saunders, 2008: 1339.
143. Cheng TO. Percutaneous coronary intervention for variant angina: balloon vs. stent. Catheter Cardiovasc Interv. 2002; 56: 21.
144. Plass CA, Sabdyusheva-Litschauer I, Bernhart A, et al. Time course of endothelium-dependent and-independent coronary vasomotor response to coronary balloons and stents: comparison of plain and drug-eluting balloons and stents. J Am Coll Cardiol Intv. 2012; 5: 741-751.
145. Yuksel UC, Celik T, Iyisoy A, Kursaklioglu H, Amasyali B, Kose S. Polymorphic ventricular tachycardia induced by coronary vasospasm: a malignant case of variant angina. Int J Cardiol. 2007; 121: 210-212.
146. Chevalier P, Dacosta A, Defaye P, et al. Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. J Am Coll Cardiol. 1998; 31: 57-61.
147. Meisel SR, Mazur A, Chetboun I, et al. Usefulness of implantable cardioverter-defibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. Am J Cardiol. 2002; 89: 1114-1116.
148. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988; 78: 1-9.
149. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J. 1996; 17: 1015-1021.
150. Freedman SB, Richmond DR, Alwyn M, Kelly DT. Late follow-up (41 to 102 months) of medically treated patients with coronary artery spasm and minor atherosclerotic coronary obstructions. Am J Cardiol. 1986; 57: 1261-1263.
151. Ong P, Athanasiadis A, Borgulya G, Voehringer M, Sechtem U.3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up. J Am Coll Cardiol. 2011; 57: 147-152.
152. Walling A, Waters DD, Miller DD, Roy D, Pelletier GB, Théroux P. Long-term prognosis of patients with variant angina. Circulation. 1987; 76: 990-997.
153. Ueda O, Kohchi K, Kishi Y, Numano F. Long lasting spasticity in controlled vasospastic angina. Heart. 1999; 81: 528-532.